Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current maternal-infant micronutrient status and the effects on birth weight in the United Arab Emirates.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2010
Same author

Disease severity associated with cystic fibrosis mutations deltaF508 and S549R(T-->G).

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2004
Same author

Diet, clothing, sunshine exposure and micronutrient status of Arab infants and young children.

Annals of tropical paediatrics·2001
Same author

The geographic distribution of cystic fibrosis mutations gives clues about population origins.

European journal of pediatrics·2000
Same author

Genotype-phenotype correlations in cystic fibrosis: clinical severity of mutation S549R(T-->G).

The European respiratory journal·2000
Same author

Group A streptococcal throat colonization is a dynamic phenomenon.

Annals of tropical paediatrics·2000
Same journal

Quality management and the Emergency Services Enhancement Program.

Journal of quality in clinical practice·2002
Same journal

Eradicating Helicobacter pylori in patients with a past history of peptic ulcer: is the juice worth the squeeze?

Journal of quality in clinical practice·2002
Same journal

Use of clinical audit for revalidation: is it sufficiently accurate?

Journal of quality in clinical practice·2002
Same journal

A quality assurance activity to improve discharge communication with general practice.

Journal of quality in clinical practice·2002
Same journal

An evaluation of outcome after severe trauma.

Journal of quality in clinical practice·2002
Same journal

A prospective, physician self-reported adverse incident audit on a general medical unit.

Journal of quality in clinical practice·2002
See all related articles

Related Experiment Video

Updated: Jun 29, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Rational prescribing for childhood pneumonia.

K P Dawson1

  • 1Department of Paediatrics, Wairau Hospital, Blenheim, New Zealand. kenneth.dawson@nmhs.govt.nz

Journal of Quality in Clinical Practice
|March 15, 2002
PubMed
Summary
This summary is machine-generated.

This study found varied pneumonia treatment in children, often using broad-spectrum antibiotics without clear evidence. A simpler protocol with narrow-spectrum antibiotics is recommended for better outcomes and cost-effectiveness.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Experiment Videos

Last Updated: Jun 29, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Area of Science:

  • Pediatric infectious diseases
  • Clinical pharmacology
  • Hospital management

Background:

  • Community-acquired pneumonia (CAP) is a common childhood illness.
  • Current management and prescribing patterns for pediatric CAP require evaluation.
  • Evidence-based guidelines may optimize treatment strategies.

Purpose of the Study:

  • To assess pediatric CAP management and prescribing practices in a provincial hospital.
  • To identify the evidence base for treatment decisions.
  • To determine the need for standardized management guidelines.

Main Methods:

  • Retrospective audit of pediatric pneumonia case notes at Wairau Hospital, Blenheim, New Zealand.
  • Analysis of treatment regimens, antibiotic choices, and clinical outcomes.
  • Evaluation of the rationale behind prescribing patterns.

Main Results:

  • Twelve distinct treatment regimens were identified for pediatric CAP.
  • Prescribing choices often lacked a clear rational basis or microbiological support.
  • Frequent use of broad-spectrum antibiotics was observed without strong justification.
  • No significant difference in clinical efficacy was found between major treatment regimens.

Conclusions:

  • Current pediatric CAP management in the studied setting is suboptimal and costly.
  • A simplified management protocol utilizing narrow-spectrum antibiotics initially is proposed.
  • This approach is expected to be more logical, effective, and cost-efficient.